OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $46 | -99.8% | 17,892 | +72.9% | 0.01% | +150.0% |
Q3 2022 | $19,000 | -47.2% | 10,347 | -33.8% | 0.00% | -50.0% |
Q4 2020 | $36,000 | -54.4% | 15,625 | +13.5% | 0.00% | -71.4% |
Q3 2020 | $79,000 | -74.1% | 13,770 | -81.3% | 0.01% | -53.3% |
Q4 2019 | $305,000 | +281.2% | 73,511 | +198.3% | 0.03% | +400.0% |
Q3 2019 | $80,000 | +344.4% | 24,646 | +143.5% | 0.01% | +500.0% |
Q1 2019 | $18,000 | -81.1% | 10,121 | -24.7% | 0.00% | -80.0% |
Q1 2018 | $95,000 | – | 13,433 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |